| 摘要 |
<p>A compound of formula (I)
or tautomers, or stereoisomers, or solvates, or pharmaceutically acceptable salts thereof,
wherein M 1 , M 2 , L 1 , L 2 , W 1 , W 2 , X 1 , X 2 , Y 1 , Y 2 , A, R 5 and R 5a are as defined herein for the for treatment of conditions treatable by the blockade of an epithelial sodium channel, particularly conditions benefiting from mucosal hydration.</p> |
| 申请人 |
NOVARTIS AG |
发明人 |
FAIRHURST, ROBIN ALEC;BUTLER, REBECCA;OAKLEY, PAUL;COLLINGWOOD, STEPHEN PAUL;SMITH, NICHOLA;STANLEY, EMILY;RODRIGUEZ PEREZ, MARIA INES |
